The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation
Abstract Background Functional performance as measured by the Karnofsky Performance Status (KPS) scale has been linked to the outcomes of liver transplant patients; however, the effect of KPS on the outcomes of the hepatocellular carcinoma (HCC) liver transplant population has not been fully elucida...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-024-03161-7 |
_version_ | 1827327285994192896 |
---|---|
author | Jie Zhou Danni Ye Siyao Zhang Jiawei Ding Tao Zhang Zheng Chen Fangshen Xu Shenli Ren Zhenhua Hu |
author_facet | Jie Zhou Danni Ye Siyao Zhang Jiawei Ding Tao Zhang Zheng Chen Fangshen Xu Shenli Ren Zhenhua Hu |
author_sort | Jie Zhou |
collection | DOAJ |
description | Abstract Background Functional performance as measured by the Karnofsky Performance Status (KPS) scale has been linked to the outcomes of liver transplant patients; however, the effect of KPS on the outcomes of the hepatocellular carcinoma (HCC) liver transplant population has not been fully elucidated. We aimed to investigate the association between pre-transplant KPS score and long-term outcomes in HCC patients listed for liver transplantation. Methods Adult HCC candidates listed on the Scientific Registry of Transplant Recipients (SRTR) database from January 1, 2011 to December 31, 2017 were grouped into group I (KPS 80–100%, n = 8,379), group II (KPS 50–70%, n = 8,091), and group III (KPS 10–40%, n = 1,256) based on percentage KPS score at listing. Survival was compared and multivariable analysis was performed to identify independent predictors. Results Patients with low KPS score had a higher risk of removal from the waiting list. The 5-year intent-to-treat survival was 57.7% in group I, 53.2% in group II and 46.7% in group III (P < 0.001). The corresponding overall survival was 77.6%, 73.7% and 66.3% in three groups, respectively (P < 0.001). Multivariable analysis demonstrated that KPS was an independent predictor of intent-to-treat survival (P < 0.001, reference group I; HR 1.19 [95%CI 1.07–1.31] for group II, P = 0.001; HR 1.63 [95%CI 1.34–1.99] for group III, P < 0.001) and overall survival(P < 0.001, reference group I; HR 1.16 [95%CI 1.05–1.28] for group II, P = 0.004; HR 1.53 [95%CI 1.26–1.87] for group III, P < 0.001). The cumulative 5-year recurrence rates was higher in group III patients (7.4%), compared with 5.2% in group I and 5.5% in group II (P = 0.037). However, this was not significant in the competing regression analysis. Conclusions Low pre-transplant KPS score is associated with inferior long-term survival in liver transplant HCC patients, but is not significantly associated with post-transplant tumor recurrence. |
first_indexed | 2024-03-07T14:58:59Z |
format | Article |
id | doaj.art-ed6cc8bd435d4965bb9eab345295af47 |
institution | Directory Open Access Journal |
issn | 1471-230X |
language | English |
last_indexed | 2024-03-07T14:58:59Z |
publishDate | 2024-02-01 |
publisher | BMC |
record_format | Article |
series | BMC Gastroenterology |
spelling | doaj.art-ed6cc8bd435d4965bb9eab345295af472024-03-05T19:18:11ZengBMCBMC Gastroenterology1471-230X2024-02-012411910.1186/s12876-024-03161-7The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantationJie Zhou0Danni Ye1Siyao Zhang2Jiawei Ding3Tao Zhang4Zheng Chen5Fangshen Xu6Shenli Ren7Zhenhua Hu8Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang UniversityDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afliated Hospital, School of Medicine, Zhejiang UniversityAbstract Background Functional performance as measured by the Karnofsky Performance Status (KPS) scale has been linked to the outcomes of liver transplant patients; however, the effect of KPS on the outcomes of the hepatocellular carcinoma (HCC) liver transplant population has not been fully elucidated. We aimed to investigate the association between pre-transplant KPS score and long-term outcomes in HCC patients listed for liver transplantation. Methods Adult HCC candidates listed on the Scientific Registry of Transplant Recipients (SRTR) database from January 1, 2011 to December 31, 2017 were grouped into group I (KPS 80–100%, n = 8,379), group II (KPS 50–70%, n = 8,091), and group III (KPS 10–40%, n = 1,256) based on percentage KPS score at listing. Survival was compared and multivariable analysis was performed to identify independent predictors. Results Patients with low KPS score had a higher risk of removal from the waiting list. The 5-year intent-to-treat survival was 57.7% in group I, 53.2% in group II and 46.7% in group III (P < 0.001). The corresponding overall survival was 77.6%, 73.7% and 66.3% in three groups, respectively (P < 0.001). Multivariable analysis demonstrated that KPS was an independent predictor of intent-to-treat survival (P < 0.001, reference group I; HR 1.19 [95%CI 1.07–1.31] for group II, P = 0.001; HR 1.63 [95%CI 1.34–1.99] for group III, P < 0.001) and overall survival(P < 0.001, reference group I; HR 1.16 [95%CI 1.05–1.28] for group II, P = 0.004; HR 1.53 [95%CI 1.26–1.87] for group III, P < 0.001). The cumulative 5-year recurrence rates was higher in group III patients (7.4%), compared with 5.2% in group I and 5.5% in group II (P = 0.037). However, this was not significant in the competing regression analysis. Conclusions Low pre-transplant KPS score is associated with inferior long-term survival in liver transplant HCC patients, but is not significantly associated with post-transplant tumor recurrence.https://doi.org/10.1186/s12876-024-03161-7Liver transplantationHepatocellular carcinomaKarnofsky Performance Status scaleWaiting listIntent-to-treat survivalTumor recurrence |
spellingShingle | Jie Zhou Danni Ye Siyao Zhang Jiawei Ding Tao Zhang Zheng Chen Fangshen Xu Shenli Ren Zhenhua Hu The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation BMC Gastroenterology Liver transplantation Hepatocellular carcinoma Karnofsky Performance Status scale Waiting list Intent-to-treat survival Tumor recurrence |
title | The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation |
title_full | The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation |
title_fullStr | The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation |
title_full_unstemmed | The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation |
title_short | The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation |
title_sort | impact of karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation |
topic | Liver transplantation Hepatocellular carcinoma Karnofsky Performance Status scale Waiting list Intent-to-treat survival Tumor recurrence |
url | https://doi.org/10.1186/s12876-024-03161-7 |
work_keys_str_mv | AT jiezhou theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT danniye theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT siyaozhang theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT jiaweiding theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT taozhang theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT zhengchen theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT fangshenxu theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT shenliren theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT zhenhuahu theimpactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT jiezhou impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT danniye impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT siyaozhang impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT jiaweiding impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT taozhang impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT zhengchen impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT fangshenxu impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT shenliren impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation AT zhenhuahu impactofkarnofskyperformancestatusonprognosisofpatientswithhepatocellularcarcinomainlivertransplantation |